AF
URGN icon

Allworth Financial’s UroGen Pharma URGN Stock Holding History

Allworth Financial’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.87K Buy
241
+196
+436% +$5.31K ﹤0.01% 3795
2026
Q1 		$810 Buy
45
+10
+29% +$200 ﹤0.01% 4625
2025
Q4 		$820 Sell
35
-114
-77% -$2.47K ﹤0.01% 4415
2025
Q3 		$2.97K Buy
149
+136
+1,046% +$2.44K ﹤0.01% 3826
2025
Q2 		$179 Buy
+13
New +$125 ﹤0.01% 4335

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Allworth Financial's URGN Position: Q2 2026 in Review

Allworth Financial increased its UroGen Pharma (URGN) stake by 436% in Q2 2026, buying an estimated $5.31K and bringing the position to 241 shares worth $8.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3795.

Allworth Financial first reported a position in URGN in Q2 2025 and has held it in 5 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Allworth Financial held 241 shares of UroGen Pharma worth $8.87K as of Q2 2026.
  • Allworth Financial bought 196 UroGen Pharma shares in Q2 2026, an estimated $5.31K.
  • UroGen Pharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3795 holding.
  • Allworth Financial first reported a position in UroGen Pharma in Q2 2025 and has held it in 5 quarters since.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.